SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-041665
Filing Date
2021-02-12
Accepted
2021-02-12 16:31:01
Documents
1
Group Members
CHART WESTCOTTIKARIAN HEALTHCARE FUND GP, L.P.IKARIAN HEALTHCARE MASTER FUND, L.P.NEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d263664dsc13ga.htm SC 13G/A 107426
  Complete submission text file 0001193125-21-041665.txt   109301
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88372 | Film No.: 21628180
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A